Edesa Biotech is trading 13.11% down at $3.05, with no clear company-specific catalyst identified for October 12, 2026. - The company’s news page lists its latest releases as August 19, with no October 12 announcement shown. - The supplied market snapshot is mixed, with no index move above 0.5% clearly explaining the decline. - Available evidence does not establish a specific reason for the sharp drop.